[Congressional Bills 115th Congress]
[From the U.S. Government Publishing Office]
[H.R. 1732 Introduced in House (IH)]
<DOC>
115th CONGRESS
1st Session
H. R. 1732
To amend the Controlled Substances Act to add certain synthetic
substances to schedule I, and for other purposes.
_______________________________________________________________________
IN THE HOUSE OF REPRESENTATIVES
March 27, 2017
Mr. Dent (for himself, Mr. Himes, and Mr. Barletta) introduced the
following bill; which was referred to the Committee on Energy and
Commerce, and in addition to the Committee on the Judiciary, for a
period to be subsequently determined by the Speaker, in each case for
consideration of such provisions as fall within the jurisdiction of the
committee concerned
_______________________________________________________________________
A BILL
To amend the Controlled Substances Act to add certain synthetic
substances to schedule I, and for other purposes.
Be it enacted by the Senate and House of Representatives of the
United States of America in Congress assembled,
SECTION 1. SHORT TITLE.
This Act may be cited as the ``Synthetic Drug Control Act of
2017''.
SEC. 2. TREATMENT OF CERTAIN DESIGNER DRUGS AS SCHEDULE I CONTROLLED
SUBSTANCES.
(a) In General.--Not later than 180 days after the date of
enactment of this Act, the Attorney General of the United States shall
update schedule I under section 202(c) of the Controlled Substances Act
(21 U.S.C. 812(c)) to include, unless specifically exempted or unless
listed in another schedule, any material, compound, mixture, or
preparation which contains any quantity of a substance listed in
paragraphs (1) through (9), or which contains the salts, isomers, and
salts of isomers thereof whenever the existence of such salts, isomers,
and salts of isomers is possible within the specific chemical
designation. The substances referred to in the preceding sentence are
the following:
(1) Phenylalkylamines.--The substances listed in this
paragraph consist of the following phenylalkylamines:
(A) 1-(4-Ethylphenyl)-2-(methylamino)-1-propanone.
(B) 1-(4-Methoxyphenyl)-2-(methylamino)-1-
propanone.
(C) 2-(Ethylamino)-1-(4-methoxyphenyl)-1-propanone.
(D) 1-(1,3-Benzodioxol-5-yl)-2-(ethylamino)-1-
propanone.
(E) 2-(Ethylamino)-1-phenyl-1-propanone.
(F) 1-Phenyl-2-(1-pyrrolidinyl)-1-propanone.
(G) 1-(4-Methoxyphenyl)-2-(1-pyrrolidinyl)-1-
propanone.
(H) 1-(1,3-Benzodioxol-5-yl)-2-(1-pyrrolidinyl)-1-
propanone.
(I) 2-Amino-1-(4-fluorophenyl)propan-1-one.
(J) 2-(Ethylamino)-1-(4-ethylphenyl)-1-propanone.
(K) 2-(Dimethylamino)-1-phenyl-1-propanone.
(L) 1-(1,3-Benzodioxol-5-yl)-2-(1-pyrrolidinyl)-1-
butanone.
(M) 1-(4-Methylphenyl)-2-(1-pyrrolidinyl)-1-
hexanone.
(N) 2-(Methylamino)-1-phenyl-1-butanone.
(O) 2-(Methylamino)-1-(4-methylphenyl)-1-butanone.
(P) 1-(4-Methylphenyl)-2-(1-pyrrolidinyl)-1-
butanone.
(Q) 1-(3,4-Dimethylphenyl)-2-(methylamino)-1-
propanone.
(R) 1-(1,3-Benzodioxol-5-yl)-2-(dimethylamino)-1-
propanone.
(S) 2-(Benzylamino)-1-(4-methylphenyl)-1-propanone.
(T) 1-(1-Naphthyl)-2-(1-pyrrolidinyl)-1-pentanone.
(U) 1-(1,3-Benzodioxol-5-yl)-2-(benzylamino)-1-
propanone.
(V) 1-(1,3-Benzodioxol-5-yl)-2-(benzylamino)-1-
butanone.
(W) 1-(1,3-Benzodioxol-2-yl)-2-(N-hydroxy-N-
methylamino)-1-propanone.
(X) 1-(1,3-Benzodioxol-5-yl)-2-(dimethylamino)-1-
butanone.
(Y) 2-(Ethyl(methyl)amino)-1-phenylbutan-1-one.
(Z) 1-(4-Bromophenyl)-2-(methylamino)-1-propanone.
(AA) 2-[Ethyl(methyl)amino]-1-phenyl-1-propanone.
(BB) 2-(Methylamino)-1-(3-methylphenyl)-1-
propanone.
(CC) 2-(1-Pyrrolidinyl)-1-(2-thiophenyl)-1-
pentanone.
(DD) 1-(4-Fluorophenyl)-2-(methylamino)-1-butanone.
(EE) 1-(4-Methoxyphenyl)-2-(1-pyrrolidinyl)-1-
butanone.
(FF) 1-(4-Ethylphenyl)-2-(1-pyrrolidinyl)-1-
butanone.
(GG) 1-(4-Methoxy-3-methylphenyl)-2-(methylamino)-
1-propanone.
(HH) 2-(Ethylamino)-1-(3-methylphenyl)-1-propanone.
(II) 2-Amino-1-(1H-indol-5-yl)-1-propanone.
(JJ) 1-Phenyl-2-(1-piperidinyl)-1-butanone.
(KK) 2-(Methylamino)-1-(2,4,5-trimethylphenyl)-1-
propanone.
(LL) 1-Phenyl-2-(1-pyrrolidinyl)-1-heptanone.
(MM) 1-Phenyl-2-(1-pyrrolidinyl)-1-hexanone.
(NN) 1-(4-Fluorophenyl)-2-(1-pyrrolidinyl)-1-
pentanone.
(OO) 1-(1,3-Benzodioxol-5-yl)-2-(dimethylamino)-1-
pentanone.
(PP) 1-(2-Fluorophenyl)-N-methyl-2-propanamine.
(QQ) 1-(2-Fluorophenyl)-2-propanamine.
(RR) 1-(3-Fluorophenyl)-2-propanamine.
(SS) 1-(3-Fluorophenyl)-N-methyl-2-propanamine.
(TT) 1-(4-Fluorophenyl)-2-propanamine.
(UU) 1-(4-Fluorophenyl)-N-methyl-2-propanamine.
(VV) 1-(4-Methylphenyl)-2-propanamine.
(WW) N-Ethyl-N-methyl-1-phenyl-2-propanamine.
(XX) 1-(1-Benzofuran-4-yl)-2-propanamine.
(YY) 1-(1-Benzofuran-5-yl)-2-propanamine.
(ZZ) 1-(2,3-Dihydro-1-benzofuran-5-yl)-2-
propanamine.
(AAA) 1-(1-Benzofuran-6-yl)-2-propanamine.
(BBB) 1-(2,3-Dihydro-1-benzofuran-6-yl)-2-
propanamine.
(CCC) 1-(4-Methoxyphenyl)-N-methyl-2-propanamine.
(DDD) N,N-Dimethyl-1-phenyl-2-propanamine.
(EEE) 1-(2,3-Dihydro-1H-inden-5-yl)-2-propanamine.
(FFF) 5,6,7,8-Tetrahydronaphtho[2,3-d][1,3]dioxol-
6-amine.
(GGG) 1-[4-(Methylsulfanyl)phenyl]-2-propanamine.
(HHH) 1-(4-Chlorophenyl)-2-propanamine.
(III) 1-(2,4,6-Trimethoxyphenyl)-2-propanamine.
(JJJ) 1-(2,4,5-Trimethoxyphenyl)-2-propanamine.
(KKK) 1-(2,5-Dimethylphenyl)-2-propanamine.
(LLL) 1-(3,4-Dimethylphenyl)-2-propanamine.
(MMM) N-(1-Phenyl-2-propanyl)-1-propanamine.
(NNN) 1-(1,3-Benzodioxol-5-yl)-N,N-dimethyl-2-
propanamine.
(OOO) N-Ethyl-1-(4-methoxyphenyl)-2-propanamine.
(PPP) 1-(1-Benzofuran-5-yl)-N-methyl-2-propanamine.
(QQQ) 6,7-Dihydro-5H-indeno[5,6-d][1,3]dioxol-6-
amine.
(RRR) 5-Iodo-2-indanamine.
(SSS) N-Methyl-6,7-dihydro-5H-indeno[5,6-
d][1,3]dioxol-6-amine.
(TTT) N-Methyl-2-indanamine.
(UUU) 2-{4-[(2-Fluoroethyl)sulfanyl]-2,5-
dimethoxyphenyl}ethanamine.
(VVV) 2-(8-Bromo-2,3,6,7-tetrahydrofuro[2,3-
f][1]benzofuran-4-yl)ethanamine.
(WWW) 2-(2,5-Dimethoxy-3,4-
dimethylphenyl)ethanamine.
(XXX) 2-(2,5-Dimethoxy-4-methylphenyl)-N-(2-
methoxybenzyl)ethanamine.
(YYY) 2-(4-Ethyl-2,5-dimethoxyphenyl)-N-(2-
methoxybenzyl)ethanamine.
(ZZZ) 2-(2,5-Dimethoxy-3,4-dimethylphenyl)-N-(2-
methoxybenzyl)ethanamine.
(AAAA) 2-(2,5-Dimethoxyphenyl)-N-(2-
methoxybenzyl)ethanamine.
(BBBB) 2-(2,5-Dimethoxy-4-nitrophenyl)-N-(2-
methoxybenzyl)ethanamine.
(CCCC) 1-(8-Bromofuro[2,3-f][1]benzofuran-4-yl)-2-
propanamine.
(DDDD) 1-(4-Chloro-2,5-dimethoxyphenyl)-2-
propanamine.
(EEEE) 1-(8-Bromo-2,3,6,7-tetrahydrobenzo[1,2-
b:4,5-b']difuran-4-yl)propan-2-amine.
(FFFF) 1-[4-(Ethylsulfanyl)-2,5-dimethoxyphenyl]-2-
propanamine.
(GGGG) 1-(4-Ethoxy-2,5-dimethoxyphenyl)-2-
propanamine.
(HHHH) 1-[2,5-Dimethoxy-4-(propylsulfanyl)phenyl]-
2-propanamine.
(IIII) 6-Chloro-1,2,3,4-tetrahydro-1-
naphthalenamine.
(JJJJ) N-Methyl-3-phenylbicyclo[2.2.1]heptan-2-
amine.
(KKKK) 1-(2-Methoxyphenyl)-N-methyl-2-propanamine.
(LLLL) 2-[4-(Allyloxy)-3,5-
dimethoxyphenyl]ethanamine.
(MMMM) 4-Methyl-2-hexanamine.
(NNNN) 4-Methyl-5-phenyl-4,5-dihydro-1,3-oxazol-2-
amine.
(OOOO) N-Methyl-1-(2-thienyl)-2-propanamine.
(PPPP) 3-(Dimethylamino)-2,2-dimethylpropyl 4-
aminobenzoate.
(QQQQ) 4-Methyl-5-(4-methylphenyl)-4,5-dihydro-1,3-
oxazol-2-amine.
(RRRR) 1-Phenyl-2-(1-pyrrolidinyl)-1-propanol.
(2) Cannabimimetic agents.--The substances listed in this
paragraph consist of the following cannabimimetic agents:
(A) (4-Ethyl-1-naphthyl)(1-pentyl-1H-indol-3-
yl)methanone.
(B) 2-(2-Methylphenyl)-1-(1-pentyl-1H-indol-3-
yl)ethanone.
(C) (2-Methyl-1-[(1-methylpiperidin-2-yl)methyl]-6-
nitro-1H-indol-3-yl)(2-naphthyl)methanone.
(D) (1-Butyl-1H-indol-3-yl)(4-
methoxyphenyl)methanone.
(E) (1-Butyl-1H-indol-3-yl)(4-methyl-1-
naphthyl)methanone.
(F) [1-(5-Fluoropentyl)-1H-indol-3-yl](4-methyl-1-
naphthyl)methanone.
(G) {1-[(1-Methyl-2-piperidinyl)methyl]-1H-indol-3-
yl}(1-naphthyl)methanone.
(H) 2-(3-Methoxyphenyl)-1-(1-pentyl-1H-indol-3-
yl)ethanone.
(I) (2-Iodophenyl){1-[(1-methyl-2-
piperidinyl)methyl]-1H-indol-3-yl}methanone.
(J) Adamantan-1-yl{1-[(1-methyl-2-
piperidinyl)methyl]-1H-indol-3-yl}methanone.
(K) 1-Naphthyl(1-propyl-1H-indol-3-yl)methanone.
(L) 5-[3-(1-Naphthoyl)-1H-indol-1-
yl]pentanenitrile.
(M) 3-(1-Naphthylmethyl)-1-pentyl-1H-indole.
(N) (2-Methyl-1-propyl-1H-indol-3-yl)(1-
naphthyl)methanone.
(O) 1-Naphthyl[1-(4-penten-1-yl)-1H-indol-3-
yl]methanone.
(P) (4-Bromo-1-naphthyl)(1-pentyl-1H-indol-3-
yl)methanone.
(Q) (4-Fluoro-1-naphthyl)(1-pentyl-1H-indol-3-
yl)methanone.
(R) (1-Naphthyl)(1-phenyl-1H-indol-3-yl)methanone.
(S) [1-(5-Chloropentyl)-1H-indol-3-yl](2-
iodophenyl)methanone.
(T) Adamantan-1-yl(1-pentyl-1H-indol-3-
yl)methanone.
(U) (2-Iodo-5-nitrophenyl){1-[(1-methyl-2-
piperidinyl)methyl]-1H-indol-3-yl}methanone.
(V) {1-[2-(4-Morpholinyl)ethyl]-1H-indol-3-
yl}(2,2,3,3-tetramethylcyclopropyl)methanone.
(W) [1-(Tetrahydro-2H-pyran-4-ylmethyl)-1H-indol-3-
yl](2,2,3,3-tetramethylcyclopropyl)methanone.
(X) N-(Adamantan-1-yl)-1-pentyl-1H-indole-3-
carboxamide.
(Y) N-(Adamantan-1-yl)-1-(5-fluoropentyl)-1H-
indole-3-carboxamide.
(Z) [1-(5-Chloropentyl)-1H-indol-3-yl](2,2,3,3-
tetramethylcyclopropyl)methanone.
(AA) [1-(3-Methylbutyl)-1H-indol-3-yl](1-
naphthyl)methanone.
(BB) N-(Adamantan-1-yl)-1-(5-fluoropentyl)-1H-
indazole-3-carboxamide.
(CC) (1-Pentyl-1H-indol-3-yl)(4-propyl-1-
naphthyl)methanone.
(DD) [1-(5-Chloropentyl)-1H-indol-3-yl](2,2,3,3-
tetramethylcyclopropyl)methanone.
(EE) (4-Methyl-1-naphthyl)[1-(4-penten-1-yl)-1H-
indol-3-yl]methanone.
(FF) (2-Methoxy-1-naphthyl)(1-pentyl-1H-indol-3-
yl)methanone.
(GG) (3-Methoxyphenyl)(1-pentyl-1H-indol-3-
yl)methanone.
(HH) (4-Ethyl-1-naphthyl)[1-(5-fluoropentyl)-1H-
indol-3-yl]methanone.
(II) 8-Quinolinyl 1-(cyclohexylmethyl)-1H-indole-3-
carboxylate.
(JJ) 1-(5-Fluoropentyl)-N-(1-naphthyl)-1H-indole-3-
carboxamide.
(KK) N-(1-Amino-3,3-dimethyl-1-oxo-2-butanyl)-1-(4-
fluorobenzyl)-1H-indazole-3-carboxamide.
(LL) N-(1-Amino-3,3-dimethyl-1-oxo-2-butanyl)-1-
pentyl-1H-indole-3-carboxamide.
(MM) (2-Iodophenyl)(1-pentyl-1H-indol-3-
yl)methanone.
(NN) [5-(2-Methylphenyl)-1-pentyl-1H-pyrrol-3-
yl](1-naphthyl)methanone.
(OO) N-(1-Naphthyl)-1-pentyl-1H-indole-3-
carboxamide.
(PP) [1-(5-Chloropentyl)-1H-indol-3-yl](4-methyl-1-
naphthyl)methanone.
(QQ) (4-Methyl-1-naphthyl)(2-methyl-1-pent-4-enyl-
1H-indol-3-yl)methanone.
(RR) (2-Methylphenyl)[1-(5-fluoropentyl)-1H-indol-
3-yl]methanone.
(SS) (2-Ethylphenyl)[1-(5-fluoropentyl)-1H-indol-3-
yl]methanone.
(TT) [1-(5-Chloropentyl)-1H-indol-3-yl](1-
naphthyl)methanone.
(UU) [1-(5-Bromopentyl)-1H-indol-3-yl](1-
naphthyl)methanone.
(VV) {1-[(1-Methyl-2-piperidinyl)methyl]-1H-indol-
3-yl}(2,2,3,3-tetramethylcyclopropyl)methanone.
(WW) [1-(1-Methylazepan-2-yl)-1H-indol-3-
yl](2,2,3,3-tetramethylcyclopropyl)methanone.
(XX) 4-Hydroxy-3,3,4-trimethyl-1-(1-pentyl-1H-
indol-3-yl)-1-pentanone.
(YY) [1-(4-Fluoropentyl)-1H-indol-3-yl](1-
naphthyl)methanone.
(ZZ) 2-(2-Iodophenyl)-1-(1-pentyl-1H-indol-3-yl)-1-
ethanone.
(AAA) (2,2,3,3-Tetramethylcyclopropyl)(1-butyl-1H-
indol-3-yl)methanone.
(BBB) (2,2,3,3-Tetramethylcyclopropyl)[1-(4,4,4-
trifluorobutyl)-1H-indol-3-yl]methanone.
(CCC) 7-Methoxy-1-[2-(4-morpholinyl)ethyl]-N-
[(1S,4R)-1,3,3-trimethylbicyclo[2.2.1]hept-2-yl]-1H-
indole-3 -carboxamide.
(DDD) 8-Quinolinyl 1-(4-fluorobenzyl)-1H-indole-3-
carboxylate.
(EEE) 1-Naphthyl 1-(4-fluorobenzyl)-1H-indole-3-
carboxylate.
(FFF) N-(1-Amino-3,3-dimethyl-1-oxo-2-butanyl)-1-
(5-fluoropentyl)-1H-indole-3-carboxamide.
(GGG) [1-(4-Fluoropentyl)-1H-indol-3-yl](2,2,3,3-
tetramethylcyclopropyl)methanone.
(HHH) 1-Naphthyl(1-pentyl-1H-indazol-3-
yl)methanone.
(III) N-(1-Naphthyl)-1-pentyl-1H-indazole-3-
carboxamide.
(JJJ) 1-Naphthyl 1-(5-fluoropentyl)-1H-indole-3-
carboxylate.
(KKK) Methyl 3-methyl-2-[(1-pentylindazole-3-
carbonyl)amino]butanoate.
(LLL) Methyl 2-[[1-(5-fluoropentyl)indazole-3-
carbonyl]amino]-3-methylbutanoate.
(MMM) N-Benzyl-1-pentyl-1H-indole-3-carboxamide.
(NNN) N-Benzyl-1-(5-fluoropentyl)-1H-indole-3-
carboxamide.
(OOO) Methyl 2-({1-[(4-fluorophenyl)methyl]-1H-
indazol-3-yl}formamido)-3-methylbutanoate.
(PPP) 8-Quinolinyl 1-pentyl-1H-indazole-3-
carboxylate.
(QQQ) 8-Quinolinyl 1-(5-fluoropentyl)-1H-indazole-
3-carboxylate.
(RRR) 2-Naphthyl 1-(2-fluorophenyl)-1H-indazole-3-
carboxylate.
(SSS) [1-(4-Fluorobenzyl)-1H-indol-3-yl](2,2,3,3-
tetramethylcyclopropyl)methanone.
(TTT) 2-{[1-(5-Fluoropentyl)-1H-indol-3-
yl]formamido}-3-phenylpropanamide.
(UUU) 2-{[1-(5-Fluoropentyl)-1H-indazol-3-
yl]formamido}-3-phenylpropanamide.
(VVV) Methyl 2-{[1-(cyclohexylmethyl)-1H-indol-3-
yl]formamido}-3-methylbutanoate.
(WWW) Methyl 2-[[1-(Cyclohexylmethyl)indazole-3-
carbonyl]amino]-3,3-dimethylbutanoate.
(XXX) Methyl 2-{[1-(cyclohexylmethyl)-1H-indol-3-
yl]formamido}-3,3-dimethylbutanoate.
(YYY) [1-(5-Fluoropentyl)-1H-benzimidazol-2-yl](1-
naphthyl)methanone.
(ZZZ) [1-(4-Fluorobenzyl)-1H-indol-3-yl](1-
naphthyl)methanone.
(AAAA) Methyl 2-({1-[(4-fluorophenyl)methyl]-1H-
indazol-3-yl}formamido)-3,3-dimethylbutanoate.
(BBBB) 8-Quinolinyl 1-(4-fluorobenzyl)-1H-indazole-
3-carboxylate.
(CCCC) N-(Adamantan-1-yl)-1-(4-fluorobenzyl)-1H-
indazole-3-carboxamide.
(DDDD) N-(1-Amino-3-methyl-1-oxo-2-butanyl)-1-(5-
fluoropentyl)-1H-indole-3-carboxamide.
(EEEE) 2-[(1S,3R)-3-Hydroxycyclohexyl]-5-(2-methyl-
2-heptanyl)phenol.
(FFFF) 2-[(1S,3R)-3-Hydroxycyclohexyl]-5-(2-methyl-
2-dodecanyl)phenol.
(GGGG) 3-Hydroxy-2-[(1R)-6-isopropenyl-3-methyl-
cyclohex-2-en-1-yl]-5-pentyl-1,4-benzoquinone.
(HHHH) {4-[2,6-Dimethoxy-4-(2-methyl-2-
octanyl)phenyl]-6,6-dimethylbicyclo[3.1.1]hept-2-en-2-
yl}methanol.
(IIII) 1-Naphthyl[4-(pentyloxy)-1-
naphthyl]methanone.
(JJJJ) 3-{[2-(Hydroxymethyl)-2,3-dihydro-1H-inden-
4-yl]oxy}phenyl 4,4,4-trifluoro-1-butanesulfonate.
(KKKK) N-(1,3-Benzodioxol-5-ylmethyl)-7-methoxy-2-
oxo-8-(pentyloxy)-1,2-dihydro-3-quinolinecarboxamide.
(LLLL) N-[3-(2-Methoxyethyl)-4,5-dimethyl-2,3-
dihydro-1,3-thiazol-2-ylidene]-2,2,3,3-
tetramethylcyclopropane-1-carboxamide.
(MMMM) [5-(2-Fluorophenyl)-1-pentyl-1H-pyrrol-3-
yl](1-naphthyl)methanone.
(NNNN) 5-(4-Biphenylylmethyl)-N,N-dimethyl-1H-
tetrazole-1-carboxamide.
(OOOO) 6-Methyl-2-[(4-methylphenyl)amino]-4H-3,1-
benzoxazin-4-one.
(PPPP) 4-Hydroxy-N-[2-(4-hydroxyphenyl)ethyl]-3-
(pentylamino)benzamide.
(3) Arylcyclohexamines.--The substances listed in this
paragraph consist of the following arylcyclohexamines:
(A) 1-(3-Methoxyphenyl)-N-propylcyclohexanamine.
(B) 2-(Ethylamino)-2-(3-
methoxyphenyl)cyclohexanone.
(C) 1-Phenylcyclohexanamine.
(D) 1-[1-(1-Benzothiophen-2-
yl)cyclohexyl]piperidine.
(E) 1-[1-(4-Methylphenyl)cyclohexyl]piperidine.
(F) 1(4-Methoxyphenyl)-N-propylcyclohexanamine.
(G) 1-[1-(4-Methoxyphenyl)cyclohexyl]piperidine.
(H) 1-[1-(3-Methoxyphenyl)cyclohexyl]piperidine.
(I) 1-Phenyl-N-propylcyclohexanamine.
(J) N-(2-Methoxyethyl)-1-phenylcyclohexanamine.
(K) N-(2-Ethoxyethyl)-1-phenylcyclohexanamine.
(L) N-(3-Methoxypropyl)-1-phenylcyclohexanamine.
(M) 3-[1-(1-Piperidinyl)cyclohexyl]phenol.
(N) 2-(4-Methoxyphenyl)-2-
(methylamino)cyclohexanone.
(O) 2-(2-Chlorophenyl)-2-(ethylamino)cyclohexanone.
(4) Tryptamines.--The substances listed in this paragraph
consist of the following tryptamines:
(A) 2-(1H-Indol-3-yl)-N-methylethanamine.
(B) N-[2-(1H-Indol-3-yl)ethyl]-N-methyl-2-
propanamine.
(C) N-[2-(1H-Indol-3-yl)ethyl]-N-isopropyl-2-
propanamine.
(D) N-[2-(1H-Indol-3-yl)ethyl]-N-propyl-1-
propanamine.
(E) 3-(2-(Diethylamino)ethyl)-1H-indol-4-yl
acetate.
(F) 3-{2-[Isopropyl(methyl)amino]ethyl}-1H-indol-4-
ol.
(G) 3-[2-(Diisopropylamino)ethyl]-1H-indol-4-yl
acetate.
(H) 3-{2-[Isopropyl(methyl)amino]ethyl}-1H-indol-4-
yl acetate.
(I) 3-[2-(Dimethylamino)ethyl]-1H-indol-4-yl
acetate.
(J) 3-[2-(Diethylamino)ethyl]-1H-indol-4-ol.
(K) 3-[2-(Diisopropylamino)ethyl]-1H-indol-4-ol.
(L) 3-{2-[Ethyl(methyl)amino]ethyl}-1H-indol-4-ol.
(M) 3-{2-[Ethyl(methyl)amino]ethyl}-1H-indol-4-yl
acetate.
(N) 3-[2-(Dipropylamino)ethyl]-1H-indol-4-ol.
(O) 3-[2-(Dipropylamino)ethyl]-1H-indol-4-yl
acetate.
(P) N-(2-(5-Methoxy-1H-indol-3-yl)ethyl)-N-
methylpropan-2-amine.
(Q) 1-(5-Methoxy-1H-indol-3-yl)-2-propanamine.
(R) 3-[2-(Dimethylamino)ethyl]-1H-indol-5-yl
acetate.
(S) N-[2-(5-Methoxy-1H-indol-3-yl)ethyl]-N-
propylpropan-2-amine.
(T) N,N-Diethyl-2-(5-methoxy-1H-indol-3-
yl)ethanamine.
(U) N-Ethyl-2-(5-methoxy-1H-indol-3-yl)-N-
methylethanamine.
(5) Benzylpiperidines.--The substances listed in this
paragraph consist of the following benzylpiperidines:
(A) 2-(Diphenylmethyl)piperidine.
(B) 2-(Diphenylmethyl)pyrrolidine.
(C) Diphenyl(2-pyrrolidinyl)methanol.
(D) Methyl (3,4-dichlorophenyl)(2-
piperidinyl)acetate.
(E) Methyl (3-chlorophenyl)(2-piperidinyl)acetate.
(F) Methyl (4-methylphenyl)(2-piperidinyl)acetate.
(G) Methyl (4-fluorophenyl)(2-piperidinyl)acetate.
(H) Ethyl phenyl(2-piperidinyl)acetate.
(6) Benzodiazepines.--The substances listed in this
paragraph consist of the following benzodiazepines:
(A) 4-(2-Chlorophenyl)-2-ethyl-9-methyl-6H-
thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine.
(B) 7-Bromo-5-(2-chlorophenyl)-1,3-dihydro-2H-1,4-
benzodiazepin-2-one.
(C) 8-Bromo-1-methyl-6-phenyl-4H-
[1,2,4]triazolo[4,3-a][1,4]benzodiazepine.
(D) 3-Methyl-6-[3-
(trifluoromethyl)phenyl][1,2,4]triazolo[4,3-
b]pyridazine.
(7) Opioids and opioid-like substances.--The substances
listed in this paragraph consist of the following opioids and
opioid-like substances:
(A) 3-[2-(2-Amino-2-propanyl)-1-
hydroxycyclohexyl]phenol.
(B) 2-Methyl-N-phenyl-N-[1-(1-phenyl-2-propanyl)-4-
piperidinyl]propanamide.
(C) 1-Cyclohexyl-4-(1,2-diphenylethyl)piperazine.
(D) N-Phenyl-N-[1-(2-thiophenylethyl)-4-
piperidinyl]acetamide.
(8) Piperazines.--The substances listed in this paragraph
consist of the following piperazines:
(A) 1,4-Dibenzylpiperazine.
(B) 1-(4-Bromo-2,5-dimethoxybenzyl)piperazine.
(C) 1-(4-Fluorophenyl)piperazine.
(D) 1-(2-Methoxyphenyl)piperazine.
(E) 1-(4-Chlorophenyl)piperazine.
(F) 1-(4-Methoxyphenyl)piperazine.
(G) 1-(3-Methylbenzyl)piperazine.
(H) 1-Benzyl-4-methylpiperazine.
(9) Tropane and alkaloids.--The substances listed in this
paragraph consist of the following tropane alkaloids:
(A) 8-Methyl-8-azabicyclo[3.2.1]oct-3-yl 4-
fluorobenzoate.
(B) Methyl 3-(4-fluorophenyl)-8-methyl-8-
azabicyclo[3.2.1]octane-2-carboxylate.
(b) Inapplicability of Other Process and Considerations.--The
Attorney General of the United States may carry out subsection (a)
without regard to the process and considerations that are otherwise
applicable under section 201 of the Controlled Substances Act (21
U.S.C. 811) for adding, removing, or transferring controlled substances
to, from, or among the schedules under section 202(c) of such Act (21
U.S.C. 812(c)).
(c) Exemption for Research.--
(1) Exemption.--Notwithstanding subsection (a), a material,
compound, mixture, or preparation described in such subsection
shall not be treated as a controlled substance for purposes of
the Controlled Substances Act (21 U.S.C. 801 et seq.) so long
as the material, compound, mixture, or preparation is
manufactured, distributed, and used exclusively for qualified
research.
(2) Qualified research defined.--In this subsection, the
term ``qualified research'' means research (as such term is
used in section 303(f) of the Controlled Substances Act (21
U.S.C. 823(f))) that is conducted by a practitioner who is
registered under such section 303(f) to conduct research with
controlled substances in schedule II, III, IV, or V (as
described in such section 303(f)).
(d) Rule of Construction.--Nothing in this section shall be
construed to limit or affect the authority of the Attorney General of
the United States to add, remove, or transfer controlled substances to,
from, or among the schedules under section 202(c) of the Controlled
Substances Act (21 U.S.C. 812(c)), including controlled substances that
have been added to a schedule pursuant to subsection (a).
<all>